"We support the FDA's decision to expand OTC access for Plan B to consumers 17 and older," TEVA's statement read. "The company believes that timely access to Plan B is extremely important, as the sooner Plan B is taken the more effective it is. We will continue to work closely with FDA to ensure that all provisions of this decision are met."
But the shift in policy could take as long as 10 months to take effect.
The first step will involve the FDA officially informing TEVA that it has permission to start marketing and selling Plan B to 17-year-olds over the counter. The company then will have to submit for a label change approval.
The FDA has said that the change will not take the entire 10 months, but spokespeople were not able to say how soon the new policy would take effect.